Evidence-based Dermatology, Second Edition is a unique book in the field of clinical dermatology. Written and edited by some of the world s leading experts in evidence-based dermatology, it takes a highly evidence-based approach to the treatment of all major and many of the less common skin conditions. The toolbox at the beginning of the book explaining how to critically appraise different studies, along with the comprehensive reviewing and appraisal of evidence in the clinical chapters makes this book distinctive in its field as do the treatment recommendations which are based on the discussion of the best available evidence using a question-driven approach and a common structure on dealing with efficacy, drawbacks and implications for clinical practice.

Evidence-based Dermatology, Second Edition is aunique book in the field of clinical dermatology. Written andedited by some of the world's leading experts inevidence-based dermatology, it takes a highly evidence-basedapproach to the treatment of all major and many of the less commonskin conditions.
The toolbox at the beginning of the book explaining how tocritically appraise different studies, along with the comprehensivereviewing and appraisal of evidence in the clinical chapters makesthis book distinctive in its field as do the treatmentrecommendations which are based on the discussion of the bestavailable evidence using a question-driven approach and a commonstructure on dealing with efficacy, drawbacks and implications forclinical practice.

CONTENTS.

.

Part I: The concept of evidence-based.

dermatology.

Andrew Herxheimer, Editor.

1. The field and its boundaries.

2. The rationale for evidence-based dermatology.

3. The role of the consumer and the public in.

evidence-based dermatology.

4. The Cochrane Skin Group.

Part II: The critical appraisal toolbox.

Michael Bigby, Editor.

5. Formulating well-built clinical questions.

6. Finding the best evidence.

7. The hierarchy of evidence.

8. Appraising systematic reviews and meta-analyses.

9. How to critically appraise a randomized controlled trial.

10. How to assess the evidence concerning the safety of medical interventions.

11. What makes a good case series?.

12. What makes a good prevalence survey?.

13. Critical appraisal of pharmacoeconomic studies.

14. Applying the evidence back to the patient.

Part III: The evidence.

Part IIIa: Common inflammatory skin diseases.

Luigi Naldi, Editor.

15. Acne vulgaris.

16. Papulopustular rosacea.

17. Perioral dermatitis.

18. Hand eczema.

19. Atopic eczema.

20. Seborrheic dermatitis.

21. Psoriasis.

22. Lichen planus.

23. Acute urticaria.

24. Chronic urticaria.

Part IIIb: Skin cancer, moles, and photoaging.

Hywel Williams, Editor.

25. Primary prevention of skin cancer.

26. Do sunscreens reduce the incidence of skin cancers?.

27. Cutaneous melanoma.

28. Squamous cell carcinoma.

29. Basal cell carcinoma.

30. Primary cutaneous T-cell lymphoma.

31. Actinic keratoses and Bowen's disease.

32. Kaposi's sarcoma.

33. Photoaging.

34. Melanocytic nevi.

Part IIIc: Infective skin diseases and.

exanthema.

Hywel Williams and Thomas Diepgen, Editors.

35. Local treatment for cutaneous warts.

36. Impetigo.

37. Athlete's foot.

38. Onychomycosis.

39. Tinea capitis.

40. Deep fungal infections.

41. Streptococcal cellulitis/erysipelas of the lower leg.

42. Exanthematic reactions.

43. Herpes simplex.

44. Leprosy.

45. Cutaneous leishmaniasis.

Part IIId: Infestations.

Berthold Rzany, Editor.

46. Scabies.

47. Head lice.

48. Insect bites and stings.

Part IIIe: Disorders of pigmentation.

Berthold Rzany, Editor.

49. Vitiligo.

50. Melasma.

Part IIIf: Hair problems.

Berthold Rzany, Editor.

51. Male and female androgenetic alopecia.

52. Alopecia areata.

53. Evidence-based treatment of hirsutism.

Part IIIg: Leg ulceration.

Berthold Rzany, Editor.

54. Venous ulcers.

Part IIIh: Other important skin disorders.

55. Cutaneous lupus erythematosus.

56. Dermatomyositis.

57. Acquired subepidermal bullous diseases.

58. Pemphigus.

59. Cutaneous sarcoidosis.

60. Erythema multiforme.

61. Stevens-Johnson syndrome and toxic epidermal necrolysis.

62. Focal hyperhidrosis.

63. Polymorphic light eruption (PLE).

64. Infantile hemangiomas and port-wine stains.

65. Psychocutaneous disease.

66. Pruritus.

67. Other skin diseases for which trials exist.

Part IV: The future of evidence-based.

dermatology.

Luigi Naldi, Editor.

68. Where do we go from here?.

Hywel Williams.

Additional chapters and resources are published on the book's web site.

(evidbasedderm.com)